与胺和胺相关的肝脏不良事件:基于人口的不成比例性分析
Angela T H Kwan1, Moiz Lakhani2, Kayla M Teopiz3
1Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
这项研究发现,在FDA不良事件报告系统 (FAERS) 中,对胺的某些肝脏问题的报告不成比例地较低. 建议在接受胺和胺治疗的患者中监测肝功能.
科学领域:
- 药物监督 药物监督 药物监督
- 肝病学 肝病学是一种肝病学.
- 药品安全 药品安全
背景情况:
- 美国食品和药物管理局的不良事件报告系统 (FAERS) 收集市场后的安全数据.
- 胺和胺越来越多地用于各种医疗条件.
- 肝胆道疾病是与药物治疗相关的潜在不良事件.
研究的目的:
- 调查与胺和胺使用相关的肝胆道疾病不成比例报告的可能性.
- 分析FAERS数据库中关于胺和胺和肝脏健康的安全信号.
主要方法:
- 使用FAERS数据库识别肝胆道疾病术语 (MedDRA).
- 员工报告概率比率 (ROR) 和信息组件 (IC025) 来评估报告的比例性.
- 与乙氨基 (阳性对照组) 和 (中性对照组) 进行比较的胺和胺报告.
主要成果:
- 与乙胺相比,胺对肝炎,肝脏疾病,肝损伤,药物诱导的肝损伤,肝功能衰竭和急性肝功能衰竭的报道不成比例地较低.
- 对胺基和乙氨基的肝功能异常和肝细胞分解报告不成比例地高.
- 对乙氨基的肝胆毒性报告不成比例,但对肝功能衰竭的报告不成比例地高.
结论:
- 研究结果表明,需要对胺和胺的潜在肝胆效应保持警.
- 建议定期监测肝功能测试,对于接受慢性胺或胺治疗的患者.
- 对于长期接受胺/胺治疗的个人,建议对肝病的症状进行临床监测.
更多相关视频
10:23Equipment Setup and Artifact Removal for Simultaneous Electroencephalogram and Functional Magnetic Resonance Imaging for Clinical Review in Epilepsy
Published on: June 23, 2023
05:42Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Parenteral Anesthetics: Overview
Analysis of Population Pharmacokinetic Data
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Factors Affecting Drug Response: Overview
